Keya Medical to Participate in NASCI 2026
Meet Keya Medical at NASCI 2026 in Denver, September 26–29, and explore comprehensive CCTA analysis with DVFFR and DVPlaque.
Comprehensive CCTA Assessment with DEEPVESSEL FFR and Plaque Analysis
Explore how quantitative plaque analysis and CT-FFR complement stenosis assessment in CCTA, including insights from COMPOSE-CT and the SCCT 2026 expert webinar.
COMPOSE-CT Validates DEEPVESSEL Plaque Against Expert Consensus
The multicenter COMPOSE-CT study demonstrated strong agreement between FDA-cleared DEEPVESSEL Plaque and Level III expert consensus for coronary plaque quantification and CAD-RADS stenosis categorization.
Can FFR-CT Reduce Unnecessary Testing in Moderate CAD?
A recent study published in REC: Interventional Cardiology (2026) explores whether adding FFR-CT (DEEPVESSEL FFR) to standard CCTA can reduce testing in moderate CAD.
AI-based FFRct: Conversation with Zwanger-Pesiri Radiology
This industry-sponsored episode of The Donut of Destiny podcast features a practical discussion on AI-based CT-derived fractional flow reserve (CT-FFR), highlighting how outpatient imaging centers are incorporating functional assessment alongside coronary CT angiography. Zwanger-Pesiri Radiology leaders discuss implementation, scalability, and clinical considerations in everyday practice.
The Future of AI and CCTA: Enhancing Decision-Making for Patient Management
Keya Medical’s webinar about the transformative role of AI and CCTA in optimizing patient management featuring Dr. John Rumberger and Dr. Asif Ali.
Recent Comments